{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:51:10Z","timestamp":1768740670111,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["INV 19-058"],"award-info":[{"award-number":["INV 19-058"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.amepre.2022.02.011","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:28:18Z","timestamp":1649143698000},"page":"168-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparing Outpatient Opioids, High-Risk Prescribing, and Opioid Poisoning Between Transgender and Cisgender Veterans: A Cross-sectional Analysis"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8280-850X","authenticated-orcid":false,"given":"Taylor L.","family":"Boyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7663-3638","authenticated-orcid":false,"given":"John R.","family":"Blosnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4516-1601","authenticated-orcid":false,"given":"Colin C.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa K.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Cashy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie J.","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2022.02.011_bib0001","series-title":"2018 Annual surveillance report of drug-related risks and outcomes\u2013United States","author":"Hoots","year":"2021"},{"key":"10.1016\/j.amepre.2022.02.011_bib0002","unstructured":"CDC WONDER. Centers for Disease Control and Prevention. http:\/\/wonder.cdc.gov\/. Updated March 14, 2022. Accessed September 17, 2021."},{"issue":"43","key":"10.1016\/j.amepre.2022.02.011_bib0003","first-page":"1487","article-title":"Vital signs: overdoses of prescription opioid pain relievers\u2014United States, 1999-2008","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.amepre.2022.02.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2020.106544","article-title":"Prevalence and correlates of substance use among transgender adults: a systematic review","volume":"111","author":"Connolly","year":"2020","journal-title":"Addict Behav"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/19361653.2020.1727814","article-title":"Substance use among transgender and cisgender high school students","volume":"18","author":"Fuxman","year":"2021","journal-title":"J LGBT Youth"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15585\/mmwr.mm6803a3","article-title":"Transgender identity and experiences of violence victimization, substance use, suicide risk, and sexual risk behaviors among high school students -19 states and large urban school districts, 2017","volume":"68","author":"Johns","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"13","key":"10.1016\/j.amepre.2022.02.011_bib0007","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMp2032447","article-title":"Ensuring that LGBTQI+ people count - collecting data on sexual orientation, gender identity, and intersex status","volume":"384","author":"Baker","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.amepre.2022.02.011_bib0008","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2105\/AJPH.2020.305722","article-title":"Sexual orientation and gender identity data collection: clinical and public health importance","volume":"110","author":"Streed","year":"2020","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0009","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08897077.2018.1544963","article-title":"Understanding and treating opioid use disorders in lesbian, gay, bisexual, transgender, and queer populations","volume":"40","author":"Girouard","year":"2019","journal-title":"Subst Abus"},{"issue":"2","key":"10.1016\/j.amepre.2022.02.011_bib0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2105\/AJPH.2018.304829","article-title":"Collecting sexual orientation and gender identity information at death","volume":"109","author":"Haas","year":"2019","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.amepre.2022.02.011_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/lgbt.2016.0026","article-title":"Measuring sexual and gender minority populations in health surveillance","volume":"4","author":"Patterson","year":"2017","journal-title":"LGBT Health"},{"issue":"4","key":"10.1016\/j.amepre.2022.02.011_bib0012","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/ADM.0000000000000769","article-title":"Disparities in documented drug use disorders between transgender and cisgender U.S. Veterans Health Administration patients","volume":"15","author":"Frost","year":"2021","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.amepre.2022.02.011_bib0013","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/lgbt.2015.0058","article-title":"Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the Veterans Health Administration: a case-control study","volume":"3","author":"Brown","year":"2016","journal-title":"LGBT Health"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0014","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.pain.2010.08.002","article-title":"Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain","volume":"151","author":"Morasco","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1370\/afm.2357","article-title":"Chronic opioid prescribing in primary care: factors and perspectives","volume":"17","author":"Tong","year":"2019","journal-title":"Ann Fam Med"},{"issue":"10","key":"10.1016\/j.amepre.2022.02.011_bib0016","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.2105\/AJPH.2013.301507","article-title":"Prevalence of gender identity disorder and suicide risk among transgender veterans utilizing veterans health administration care","volume":"103","author":"Blosnich","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amepre.2022.02.011_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2015.01.027","article-title":"Trends in abuse and misuse of prescription opioids among older adults","volume":"149","author":"West","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2105\/AJPH.2016.303591","article-title":"Suicide deaths with opioid poisoning in the United States: 1999-2014","volume":"107","author":"Braden","year":"2017","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.amepre.2022.02.011_bib0020","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11916-014-0460-1","article-title":"Suicide by means of opioid overdose in patients with chronic pain","volume":"18","author":"Madadi","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"17","key":"10.1016\/j.amepre.2022.02.011_bib0021","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMp1801417","article-title":"Suicide: a silent contributor to opioid-overdose deaths","volume":"378","author":"Oquendo","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amepre.2022.02.011_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108791","article-title":"Prevalence of substance use and substance-related disorders among U.S. Veterans Health Administration patients","volume":"225","author":"Hoggatt","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.amepre.2022.02.011_bib0023","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.2105\/AJPH.2015.302836","article-title":"Prevalence, comorbidity, and prognosis of mental health among U.S. veterans","volume":"105","author":"Trivedi","year":"2015","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0024","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1037\/a0029597","article-title":"A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the Minority Stress Model","volume":"43","author":"Hendricks","year":"2012","journal-title":"Prof Psychol Res Pract"},{"issue":"4","key":"10.1016\/j.amepre.2022.02.011_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.amepre.2016.12.019","article-title":"Impact of social determinants of health on medical conditions among transgender veterans","volume":"52","author":"Blosnich","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.amepre.2022.02.011_bib0026","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jss.2019.12.043","article-title":"Opioid consumption after gender-affirming mastectomy and two other breast surgeries","volume":"251","author":"Robinson","year":"2020","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.amepre.2022.02.011_bib0027","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/SAP.0000000000001921","article-title":"Combined general and epidural anesthesia is associated with decreased opioid consumption and enhanced pain control after penile inversion vaginoplasty in transwomen","volume":"83","author":"Salgado","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0028","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1526-4637.2011.01260.x","article-title":"A history of being prescribed controlled substances and risk of drug overdose death","volume":"13","author":"Paulozzi","year":"2012","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0029","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpain.2015.01.475","article-title":"Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in Medicaid","volume":"16","author":"Yang","year":"2015","journal-title":"J Pain"},{"issue":"13","key":"10.1016\/j.amepre.2022.02.011_bib0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2022.02.011_bib0031","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.amepre.2022.02.011_bib0032","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","article-title":"Opioid dose and drug-related mortality in patients with nonmalignant pain","volume":"171","author":"Gomes","year":"2011","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2022.02.011_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure\u2013response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2022.02.011_bib0034","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among U.S. veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.amepre.2022.02.011_bib0035","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"issue":"suppl 6","key":"10.1016\/j.amepre.2022.02.011_bib0036","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1016\/S0924-977X(99)00052-8","article-title":"The use of benzodiazepines in anxiety and other disorders","volume":"9","author":"Argyropoulos","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.amepre.2022.02.011_bib0037","series-title":"Overview of VA data, information systems, national databases and research uses","author":"Souden","year":"2018"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0038","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1089\/lgbt.2020.0235","article-title":"Suicide, homicide, and all-cause mortality among transgender and cisgender patients in the Veterans Health Administration","volume":"8","author":"Boyer","year":"2021","journal-title":"LGBT Health"},{"issue":"7","key":"10.1016\/j.amepre.2022.02.011_bib0039","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jamia\/ocy022","article-title":"Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes","volume":"25","author":"Blosnich","year":"2018","journal-title":"J Am Med Inform Assoc"},{"issue":"9","key":"10.1016\/j.amepre.2022.02.011_bib0040","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/aje\/kwab102","article-title":"Validating data-driven methods for identifying transgender individuals in the Veterans Health Administration of the US Department of Veterans Affairs","volume":"190","author":"Wolfe","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.amepre.2022.02.011_bib0041","unstructured":"County FIPS codes. U.S. Department of Agriculture, Natural Resouces Conservation Service. https:\/\/www.nrcs.usda.gov\/wps\/portal\/nrcs\/detail\/national\/home\/?cid=nrcs143_013697. Accessed November 11, 2021."},{"issue":"6","key":"10.1016\/j.amepre.2022.02.011_bib0042","first-page":"271","article-title":"Evolving sex and gender in electronic health records","volume":"36","author":"Burgess","year":"2019","journal-title":"Fed Pract"},{"issue":"8","key":"10.1016\/j.amepre.2022.02.011_bib0043","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1176\/appi.ps.201800555","article-title":"Potentially problematic opioid prescriptions among individuals with private insurance and Medicaid","volume":"70","author":"Ali","year":"2019","journal-title":"Psychiatr Serv"},{"issue":"9","key":"10.1016\/j.amepre.2022.02.011_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns\u2013prescription behavior surveillance system, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5055\/jom.2020.0568","article-title":"National gender differences in the prescribing of opioid medications from 2006 to 2015","volume":"16","author":"Marie Preciado","year":"2020","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.amepre.2022.02.011_bib0046","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/MLR.0000000000001384","article-title":"Differences in methods of suicide death among transgender and nontransgender patients in the Veterans Health Administration, 1999-2016","volume":"59","author":"Blosnich","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2022.02.011_bib0047","series-title":"Veterans choice program","year":"2016"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0048","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2146\/ajhp150800","article-title":"Medication acquisition by veterans dually eligible for Veterans Affairs and Medicare Part D pharmacy benefits","volume":"74","author":"Stroupe","year":"2017","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0049","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.amepre.2022.02.011_bib0050","unstructured":"Healthcare Cost and Utilization Project (HCUP) CCS for ICD-9-CM. Agency for Healthcare Research and Quality. https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/ccs.jsp. Updated March 6, 2017. Accessed February 17, 2022."},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0051","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1536867X0400400305","article-title":"Analysis of matched cohort data","volume":"4","author":"Cummings","year":"2004","journal-title":"Stata J"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/epirev\/mxg002","article-title":"Matched cohort methods for injury research [published correction appears in Epidemiol Rev. 2004;160(3):300]","volume":"25","author":"Cummings","year":"2003","journal-title":"Epidemiol Rev"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.amepre.2022.02.011_bib0054","unstructured":"Department of Veterans Affairs. Providing Health Care for Transgender and Intersex Veterans. Washington, DC: Department of Veterans Affairs.https:\/\/www.va.gov\/vhapublications\/ViewPublication.asp?pub_ID=6431. Published June 26, 2020. Accessed September 23, 2021."},{"key":"10.1016\/j.amepre.2022.02.011_bib0055","article-title":"Plans to offer gender confirmation surgeries for transgender veterans","author":"Karni","year":"2021","journal-title":"The New York Times"},{"issue":"11","key":"10.1016\/j.amepre.2022.02.011_bib0056","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/aje\/kww112","article-title":"Controlling for informed presence bias due to the number of health encounters in an electronic health record","volume":"184","author":"Goldstein","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.amepre.2022.02.011_bib0057","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"issue":"1\u20133","key":"10.1016\/j.amepre.2022.02.011_bib0058","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2005.09.020","article-title":"Regular use of prescribed opioids: association with common psychiatric disorders","volume":"119","author":"Sullivan","year":"2005","journal-title":"Pain"},{"issue":"19","key":"10.1016\/j.amepre.2022.02.011_bib0059","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0060","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.2011.10101476","article-title":"Risk of death from accidental overdose associated with psychiatric and substance use disorders [published correction appears in Am J Psychiatry. 2012;169(1):99]","volume":"169","author":"Bohnert","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0061","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamainternmed.2017.0147","article-title":"Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs","volume":"177","author":"Gellad","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0062","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/j.pain.0000000000000837","article-title":"Impact of the opioid safety initiative on opioid-related prescribing in veterans","volume":"158","author":"Lin","year":"2017","journal-title":"Pain"},{"issue":"suppl 3","key":"10.1016\/j.amepre.2022.02.011_bib0063","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11606-020-06258-3","article-title":"Opioid prescribing and opioid risk mitigation strategies in the Veterans Health Administration","volume":"35","author":"Sandbrink","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.amepre.2022.02.011_bib0064","first-page":"2121","article-title":"Addiction: Part I. Benzodiazepines\u2013side effects, abuse risk and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amepre.2022.02.011_bib0065","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","volume":"11","author":"Garakani","year":"2020","journal-title":"Psychiatry"},{"issue":"7","key":"10.1016\/j.amepre.2022.02.011_bib0066","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/M18-2574","article-title":"Dual receipt of prescription opioids from the Department of Veterans Affairs and Medicare Part D and prescription opioid overdose death among veterans: a nested case-control study","volume":"170","author":"Moyo","year":"2019","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.amepre.2022.02.011_bib0067","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.sapharm.2018.10.023","article-title":"Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among veterans","volume":"15","author":"Moyo","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"10.1016\/j.amepre.2022.02.011_bib0068","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.amepre.2019.01.016","article-title":"Changing trends in opioid overdose deaths and prescription opioid receipt among veterans","volume":"57","author":"Lin","year":"2019","journal-title":"Am J Prev Med"},{"issue":"5","key":"10.1016\/j.amepre.2022.02.011_bib0069","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/sltb.12233","article-title":"Factors associated with suicidality among a national sample of transgender veterans","volume":"46","author":"Lehavot","year":"2016","journal-title":"Suicide Life Threat Behav"},{"issue":"3","key":"10.1016\/j.amepre.2022.02.011_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1745691618812680","article-title":"Suicide in transgender veterans: prevalence, prevention, and implications of current policy","volume":"14","author":"Tucker","year":"2019","journal-title":"Perspect Psychol Sci"},{"issue":"23","key":"10.1016\/j.amepre.2022.02.011_bib0071","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2019.16566","article-title":"Trends in intentional and unintentional opioid overdose deaths in the United States, 2000-2017","volume":"322","author":"Olfson","year":"2019","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amepre.2022.02.011_bib0072","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7326\/M18-0852","article-title":"Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare Part D and the Department of Veterans Affairs: a cross-sectional study","volume":"169","author":"Carico","year":"2018","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379722001271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379722001271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:05:50Z","timestamp":1760083550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379722001271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0749379722001271"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2022.02.011","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing Outpatient Opioids, High-Risk Prescribing, and Opioid Poisoning Between Transgender and Cisgender Veterans: A Cross-sectional Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2022.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}